Orally delivered polycurcumin responsive to bacterial reduction for targeted therapy of inflammatory bowel disease.

about

Investigation of the transport and absorption of Angelica sinensis polysaccharide through gastrointestinal tract both in vitro and in vivo.

P2860

Q50048515-D3540AC2-8B60-4875-9498-27CC6F81DDC4

P2860

Orally delivered polycurcumin responsive to bacterial reduction for targeted therapy of inflammatory bowel disease.

Item

http://www.wikidata.org/entity/Q38718154

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Orally delivered polycurcumin ...... of inflammatory bowel disease.

@en

type

Item

label

Orally delivered polycurcumin ...... of inflammatory bowel disease.

@en

prefLabel

Orally delivered polycurcumin ...... of inflammatory bowel disease.

@en

P1476

Orally delivered polycurcumin ...... of inflammatory bowel disease.

@en

P2093

Chen Kang

http://www.w3.org/2001/XMLSchema#string

Dong Fang

http://www.w3.org/2001/XMLSchema#string

Hongzhi Qiao

http://www.w3.org/2001/XMLSchema#string

Jing Chen

http://www.w3.org/2001/XMLSchema#string

Jun Chen

http://www.w3.org/2001/XMLSchema#string

Junsong Li

http://www.w3.org/2001/XMLSchema#string

Liuqing Di

http://www.w3.org/2001/XMLSchema#string

Yahan Gao

http://www.w3.org/2001/XMLSchema#string

Yuan Sun

http://www.w3.org/2001/XMLSchema#string

Zhipeng Chen

http://www.w3.org/2001/XMLSchema#string

P2860

Inflammatory bowel disease

Genetics and pathogenesis of inflammatory bowel disease

Size-dependent bioadhesion of micro- and nanoparticulate carriers to the inflamed colonic mucosa.

Microbially triggered drug delivery to the colon.

Orally delivered thioketal nanoparticles loaded with TNF-α-siRNA target inflammation and inhibit gene expression in the intestines.

Enhancement of curcumin oral absorption and pharmacokinetics of curcuminoids and curcumin metabolites in mice

Tumor necrosis factor inhibitors for inflammatory bowel disease.

Therapeutic potential of curcumin in digestive diseases

Advances in oral nano-delivery systems for colon targeted drug delivery in inflammatory bowel disease: selective targeting to diseased versus healthy tissue.

Size-dependent nanoparticulate drug delivery in inflammatory bowel diseases.

P304

233-242

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/10717544.2016.1245367

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28156160

http://www.w3.org/2001/XMLSchema#string

Orally delivered polycurcumin responsive to bacterial reduction for targeted therapy of inflammatory bowel disease.

about

P2860

P2860

Orally delivered polycurcumin responsive to bacterial reduction for targeted therapy of inflammatory bowel disease.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698